AllSpeakerThumbnail.png

IMMH2016 Online pass - full access

This purchase comes with access to the videos of all 26 presentations from the 7th annual Integrative Medicine for Mental Health (IMMH) Conference, from IMMH Fundamentals on day one to all presentations in the Main Conference.  The speakers for this year’s conference included Daniel Amen, Kelly Brogan, Richard Brown, Louis Cady, Suruchi Chandra, Bill Code, John Gannage, James Greenblatt, Andrea Gruszecki, Marty Hinz, Jay Lombard, Trudy Scott, William Shaw, Elizabeth Stuller, Kat Toups, Terry Wahls, and Kurt Woeller.  A full list of speakers, topics, and overviews can be found below.

BUY FULL ACCESS AND SAVE 50%

**CME/CEU credits cannot be obtained by watching the conference videos.**

260.00
Quantity:
Add To Cart

integrative medicine for mood and anxiety disorders - part 1

JAMES GREENBLATT, MD

The monoamine hypotheses about psychiatry and associated treatments have revealed their limitations, and it is time to explore what the literature has been supporting for two decades:  the inflammatory model of mental illness and the relevance of psychoneuroimmunology to a systems-based approach in the treatment of patients with syndromal depression. The role of cytokines and the immune system in depression is well-established as is the relationship between gut microbiota, intestinal integrity, and the brain. Exploring the gut-immune-brain connection, we must also consider the mediating role of the endocrine system. Lifestyle interventions around gut, immune, and anti-inflammatory influences will be explored, as will epigenetic modulators such as probiotics, methyl donors, and therapeutic foods.


Microorganisms and their Effects on Mental Health

WILLIAM SHAW, PHD

The monoamine hypotheses about psychiatry and associated treatments have revealed their limitations, and it is time to explore what the literature has been supporting for two decades:  the inflammatory model of mental illness and the relevance of psychoneuroimmunology to a systems-based approach in the treatment of patients with syndromal depression. The role of cytokines and the immune system in depression is well-established as is the relationship between gut microbiota, intestinal integrity, and the brain. Exploring the gut-immune-brain connection, we must also consider the mediating role of the endocrine system. Lifestyle interventions around gut, immune, and anti-inflammatory influences will be explored, as will epigenetic modulators such as probiotics, methyl donors, and therapeutic foods.


Thyroid on My Mind - An Update

LOUIS CADY, MD

The monoamine hypotheses about psychiatry and associated treatments have revealed their limitations, and it is time to explore what the literature has been supporting for two decades:  the inflammatory model of mental illness and the relevance of psychoneuroimmunology to a systems-based approach in the treatment of patients with syndromal depression. The role of cytokines and the immune system in depression is well-established as is the relationship between gut microbiota, intestinal integrity, and the brain. Exploring the gut-immune-brain connection, we must also consider the mediating role of the endocrine system. Lifestyle interventions around gut, immune, and anti-inflammatory influences will be explored, as will epigenetic modulators such as probiotics, methyl donors, and therapeutic foods.


integrative medicine for mood and anxiety disorders - part 2

JAMES GREENBLATT, MD

The monoamine hypotheses about psychiatry and associated treatments have revealed their limitations, and it is time to explore what the literature has been supporting for two decades:  the inflammatory model of mental illness and the relevance of psychoneuroimmunology to a systems-based approach in the treatment of patients with syndromal depression. The role of cytokines and the immune system in depression is well-established as is the relationship between gut microbiota, intestinal integrity, and the brain. Exploring the gut-immune-brain connection, we must also consider the mediating role of the endocrine system. Lifestyle interventions around gut, immune, and anti-inflammatory influences will be explored, as will epigenetic modulators such as probiotics, methyl donors, and therapeutic foods.


THE EFFECT OF FOOD ALLERGIES ON MENTAL HEALTH

WILLIAM SHAW, PHD

The monoamine hypotheses about psychiatry and associated treatments have revealed their limitations, and it is time to explore what the literature has been supporting for two decades:  the inflammatory model of mental illness and the relevance of psychoneuroimmunology to a systems-based approach in the treatment of patients with syndromal depression. The role of cytokines and the immune system in depression is well-established as is the relationship between gut microbiota, intestinal integrity, and the brain. Exploring the gut-immune-brain connection, we must also consider the mediating role of the endocrine system. Lifestyle interventions around gut, immune, and anti-inflammatory influences will be explored, as will epigenetic modulators such as probiotics, methyl donors, and therapeutic foods.


Radical Holism in the Management of Anxiety and Depression

KELLY BROGAN, MD

The monoamine hypotheses about psychiatry and associated treatments have revealed their limitations, and it is time to explore what the literature has been supporting for two decades:  the inflammatory model of mental illness and the relevance of psychoneuroimmunology to a systems-based approach in the treatment of patients with syndromal depression. The role of cytokines and the immune system in depression is well-established as is the relationship between gut microbiota, intestinal integrity, and the brain. Exploring the gut-immune-brain connection, we must also consider the mediating role of the endocrine system. Lifestyle interventions around gut, immune, and anti-inflammatory influences will be explored, as will epigenetic modulators such as probiotics, methyl donors, and therapeutic foods.


Medicine - A State of Crisis, A State of Change

LOUIS CADY, MD

Dr. Cady returns with one of the most requested lectures from IMMH 2015.  In this patient-centered presentation, we will consider the current market forces increasingly affecting our patients and controlling physicians, health care providers, and the medical system.    We will also review useful strategies for dealing with the force of change.  A correlated theme will be that the thoughtful practice of functional, integrative medicine is extremely difficult to “outsource” and the competent practitioner will be unique and still capable of surviving in the current marketplace.


Psychological Stress and the Gut-Brain Microbiome Axis

ANDREA GRUSZECKI, ND

The microbiome-gut-brain axis is a unique route of communication between the host and the microbiota of the gastrointestinal tract that may affect mood, immunity, and CNS function.  Stress has been shown to disrupt the gut-brain-microbiome axis through changes in the gut wall, neurotransmitter levels, and alterations in the microbiota.  Studies demonstrate alterations in microbiota populations, GI tissues, or gut-related neurotransmitters occur due to trauma or stress, and may continue to affect health and homeostasis long after the stressor is removed.  Disruptions to the microbiome can often be corrected through simple, but effective interventions, including probiotics, prebiotics, diet, and stress management.


Clinical, Ethical and Spiritual Challenges of Integrative Psychiatry

JAMES GREENBLATT, MD

This presentation will address some common clinical challenges that new practitioners face when utilizing integrative therapies.  These challenges include not understanding side effects to supplements, interactions with supplements, and underlying psychiatric disorders.  In addition, this presentation will explore the challenges of practicing outside of traditional psychiatric protocols.


How Genetics Can Change What We Think About Mental Illness

JAY LOMBARD, DO

Genetics will fundamentally transform the practice of psychiatry.  By elucidating the underlying mechanisms of depression, bipolar, and other neuropsychiatric disorders, clinicians will treat these conditions with a much higher degree of specificity.  Dr. Lombard will discuss some of the most important breakthroughs in the fields of genetics and psychiatry and will specifically highlight those findings which are applicable to the current care of patients.


Autism Spectrum Disorders

KURT WOELLER, DO

Integrative medicine is well-suited to address the many complex medical needs of individuals on the autism spectrum.  For too long, the conventional medical community has ignored the common co-morbid conditions of this group of individuals.  Many of these health problems can be successfully treated with integrative medicine.  This presentation will provide a roadmap for testing and treatment options to help more patients with autism in your practice.


healing emotional and physical trauma

DANIEL AMEN, MD

In this talk, Dr. Amen will share his research from the world’s largest brain imaging study, showing the impact of both posttraumatic stress disorder and traumatic brain injury on the brain, as well as practical strategies to help heal the brain in both of these diagnoses.


Neuropsychiatric Lyme Disease and Associated Co-Infections

SURUCHI CHANDRA, MD

Lyme disease is one of the fastest growing infectious diseases in the United States.  It can remain dormant for years and then later mimic a number of psychiatric illnesses, including anxiety disorders, mood disturbances, psychosis, and autism-like behaviors.  It can be further complicated by the presence of co-infections.  Both the diagnosis and treatment of these infections in the chronic stage can be challenging.  We will review both standard treatment recommendations and integrative and holistic approaches, including dietary changes, herbal medicines, and nutritional supplements.


Anxiety and Targeted Individual Amino Acids

TRUDY SCOTT, CN

This presentation will cover the use of targeted individual amino acids for the immediate relief of anxiety symptoms.  Strategies for using tryptophan and 5-HTP for the low serotonin type of anxiety, and GABA for the more physical type of anxiety will be discussed, including how to determine each person’s unique needs and when to use which amino acid, starting and maximum doses, how to do a trial and why this is so effective, precautions when using these amino acids, the best forms of these amino acids, working with children, and case studies.  Controversies around the serotonin hypothesis, the GABA blood-brain-barrier issue, and neurotransmitter testing will also be addressed.


Orthomolecular Health: The Benefits of Low Dose Lithium

JAMES GREENBLATT, MD

This lecture will discuss the use of low dose lithium in neuro-psychiatric illnesses, including behavioral problems with children, depression, and anxiety, as well as new research looking at lithium for dementia and cognitive decline. This lecture will review protocols for prevention and treatment.


Serotonin, Dopamine, and Thiol Related Nutritional Deficiencies

MARTY HINZ, MD

Relative nutritional deficiencies (RNDs) occur when an optimal diet will not meet system needs.  Virtually all diseases associated with low or inadequate concentrations of serotonin, catecholamines, and/or thiols are associated with one or more relative nutritional deficiencies.  Most neurotransmitter related diseases have multiple RNDs.  As documented in his 22 peer-reviewed medical journal publications, drugs, disease, and nutrients can induce RNDs. This lecture will help the caregiver identify and manage nutritional deficiency problems which in the past may have been managed inappropriately or ineffectively with drugs.


Statins, Cholesterol Deficiency and Mental Health

WILLIAM SHAW, PHD

Case series and data from adverse drug reaction reports have demonstrated the occurrence of psychiatric reactions associated with statin treatment of high cholesterol.  Although high cholesterol may be associated with heart disease, low cholesterol is associated with a variety of illnesses such as impaired immunity, cancer, violence, and cognitive impairment. The genetic, nutritional, and drug effects on cholesterol metabolism and the potential benefits of increasing cholesterol in the treatment of psychiatric disorders will be reviewed in detail.


Clinical Intake for Autism: Questions You MUST Ask and Why

KURT WOELLER, DO

There is a tremendous amount of information about an individual’s autism spectrum disorder that can be obtained from a clinical intake.  This information can then be correlated to prepare a comprehensive intervention program.  This presentation will cover many of the “must ask” questions of parents or caregivers to improve your history of a new patient on the spectrum.


Feeding the Brain and Microbiome for Better Mental Health

TERRY WAHLS, MD

Dr. Wahls will discuss the diet and lifestyle choices that she used to recover her function after four years in a tilt/recline wheelchair due to progressive multiple sclerosis.  She will also review the research on the microbiome of hunter gatherer, primitive farmer, and western urban dweller societies.  In addition, she will discuss food strategies to improve the diversity of species in the microbiome of urban dwellers to improve mental health, physical health, and vitality.


Cutting Edge Modalities in Addiction Psychiatry

ELIZABETH STULLER, MD

Addiction Psychiatry is one of the most exciting and rapidly advancing areas of medical science. This lecture will explore the use of cutting edge modalities such as neuroimaging and advanced biomarker and genetic testing, as well as offer an expanded perspective in the treatment of adolescent and adult addiction.  It will also provide an understanding of the role of the neuro-endocrine-immune supersystem in empowering clinicians to develop more effective and targeted treatment strategies for their patients.


Environmental Medicine: The Role of Toxins in Children’s Mental Health

JOHN GANNAGE, MD

At a time of unprecedented chemical production and human exposure to environmental toxicants, Dr. Gannage will explore their impact on mental health, particularly in children.  Disorders of neurodevelopment are a global pandemic, with toxins such as heavy metals, pesticides and petroleum-derived products having a major impact.  Concepts such as early programming, the susceptibility of children, immature detoxification, retention toxicity, maternal-fetal transfer and epigenetics will be discussed.  Research will be presented correlating exposure to ADHD and autism in particular.


New Ways of Understanding and Addressing OCD Behaviors

SURUCHI CHANDRA, MD

Obsessive and compulsive behaviors should be viewed as symptoms of a disease-regulated system rather than a disease or disorder.  In this talk, Dr. Chandra will review emerging research about the relationship between obsessive and compulsive behaviors and the gastrointestinal system, microbiome, and the immune system.  She will also discuss holistic and integrative ways of addressing these imbalances.


Non Drug Treatments for AD(H)D

RICHARD BROWN, MD

ADHD is not just a disorder of attention and hyperactivity.  It also involves social interactions, bodily awareness, anxiety, reward systems, and numerous co-occurring learning disabilities.  Recent research is shedding light on the role of polymorphisms (genetic variants) that help explain some of the variability in medication responsiveness and nutritional sensitivities.  Brain studies showing differences in activation of neural networks are being used to improve the effectiveness of neurofeedback.  Some of this important research will be reviewed and the use of evidence-based herbs, nutrients, mind-body approaches, neurofeedback, and mild brain stimulation treatments will also be discussed.


Integrative Approaches to Treating Multiple Sclerosis

BILL CODE, MD

This presentation will emphasize the gut-brain connection with multiple sclerosis.  It will also review various integrative approaches to treating MS, including recent literature about anti-inflammatory diets, using hyperbaric oxygen therapy to target hypoxia (a deficiency in the amount of oxygen that reaches the tissues), and the potential of fecal microbial implants.


Mind Body Practices for Post-Traumatic Stress Disorder

RICHARD BROWN, MD

Voluntarily regulated breathing practices (VRBPs) rapidly improve sympatho-vagal balance, emotion regulation, and symptom resolution in a wide variety of disorders and patient populations.  Evidence that specific VRBPs in combination with other practices has resulted in significant rapid improvements in psychological and physical symptoms in generalized anxiety disorders, veterans with PTSD, healthcare providers, bowel disease, and survivors of several mass disasters will be reviewed.  Preliminary data from a mass resonance spectroscopy study of effects on brain GABA levels in patients with depression will also be presented.  Some simple movement and breath practices that can be use in private offices, clinics, hospitals, schools, military bases, and disaster sites will also be demonstrated.


Functional Medicine Psychiatry 101 - A Clinician’s Journey

KAT TOUPS, MD

What does a functional medicine approach to psychiatry look like?  Learning to resolve the root causes of psychiatric illness gives practitioners an expanded tool kit to help patients get truly well, rather than taking medications for the rest of their lives.  Learn how Dr. Toups came to embrace functional medicine and adapt this approach to working with patients suffering with all types of psychiatric disorders – even schizophrenia.  She will discuss resources for learning functional medicine psychiatry, as well as case studies to illustrate a functional approach in action.